These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35395975)

  • 1. [Effect of Acute Myeloid Leukemia Cells on the Proliferation and Apoptosis of Bone Marrow-Derived Mesenchymal Stromal Cells].
    Chen ZH; Zheng YX; Si JQ; Yuan T; Zhang ZR; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):430-434. PubMed ID: 35395975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
    Yu Z; Li D; Ju XL
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia's biological functions: a focus on the potential role of LncRNAs.
    Jalilivand S; Izadirad M; Vazifeh Shiran N; Gharehbaghian A; Naserian S
    Clin Exp Med; 2024 May; 24(1):108. PubMed ID: 38777995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
    Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
    Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients.
    von der Heide EK; Neumann M; Vosberg S; James AR; Schroeder MP; Ortiz-Tanchez J; Isaakidis K; Schlee C; Luther M; Jöhrens K; Anagnostopoulos I; Mochmann LH; Nowak D; Hofmann WK; Greif PA; Baldus CD
    Leukemia; 2017 May; 31(5):1069-1078. PubMed ID: 27833093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
    Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
    Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients].
    Zhao ZG; Sun L; Wang XF; Zhang YZ; Yu Y; Yang HL; Zou P
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):105-9. PubMed ID: 21575477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
    Corradi G; Bassani B; Simonetti G; Sangaletti S; Vadakekolathu J; Fontana MC; Pazzaglia M; Gulino A; Tripodo C; Cristiano G; Bandini L; Ottaviani E; Ocadlikova D; Piccioli M; Martinelli G; Colombo MP; Rutella S; Cavo M; Ciciarello M; Curti A
    Clin Cancer Res; 2022 Jul; 28(14):3141-3155. PubMed ID: 35349670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
    Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
    Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
    Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
    Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
    Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
    Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Newly Diagnosed Acute Myeloid Leukemia Patients-Derived Bone Marrow Mesenchymal Stem Cells Suppress Daunorubicin Induced HL-60 Cell Apoptosis via Modulating Caspase-3/Survivin].
    Ning HM; Wang J; Su YF; Xu C; Hu JW; Lou X; Li XS; Mao N; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1736-1741. PubMed ID: 31839031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stanniocalcin 1 is overexpressed in multipotent mesenchymal stromal cells from acute myeloid leukemia patients.
    Schelker RC; Kratzer A; Müller G; Brochhausen C; Hart C; Stempfl T; Heudobler D; Moehle C; Herr W; Iberl S; Grassinger J
    Hematology; 2021 Dec; 26(1):565-576. PubMed ID: 34384344
    [No Abstract]   [Full Text] [Related]  

  • 16. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone Marrow Mesenchymal Stem Cells from Newly Diagnosed Acute Myeloid Leukemia Patients Exhibit Enhanced Osteogenic Differentiation Capacity].
    Ning HM; Wang J; Su YF; Xu C; Hu JW; Lou X; Li XS; Mao N; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1277-1286. PubMed ID: 31418393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
    Battula VL; Chen Y; Cabreira Mda G; Ruvolo V; Wang Z; Ma W; Konoplev S; Shpall E; Lyons K; Strunk D; Bueso-Ramos C; Davis RE; Konopleva M; Andreeff M
    Blood; 2013 Jul; 122(3):357-66. PubMed ID: 23741006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.